Active monitoring of adverse events after the application of the 13-valente pneumococcal conjugate vaccine in oncogeriatric patients: A cohort study. (October 2022) - Sales, D.; Fonseca, E.J.; Mello, M.J.; Telles Sales, J.; Torres, L.; Leite, R.; Haimenis, B.; Pinto, A.L.; Santos, C.; Oliveira, C.; Portela, J.; Araujo, P.; et al.